Immunosuppressive therapy is valuable in aggressive multiple sclerosis.
Kilpatrick
T J
TJ
Multiple Sclerosis Research Unit, The Royal Melbourne Hospital, Melbourne, Australia.
Butzkueven
H
H
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008942:Mitoxantrone / Q000627:therapeutic use; D020528:Multiple Sclerosis, Chronic Progressive / Q000188:drug therapy*; D005719:gamma-Globulins / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D005719:gamma-Globulins; D003520:Cyclophosphamide; D008942:Mitoxantrone